HomeCompareACOPY vs ORCC

ACOPY vs ORCC: Dividend Comparison 2026

ACOPY yields 1.25% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACOPY wins by $65.00 in total portfolio value· pulled ahead in Year 10
10 years
ACOPY
ACOPY
● Live price
1.25%
Share price
$6.62
Annual div
$0.08
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.5K
Annual income
$135.86
Full ACOPY calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — ACOPY vs ORCC

📍 ACOPY pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACOPYORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACOPY + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACOPY pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACOPY
Annual income on $10K today (after 15% tax)
$106.47/yr
After 10yr DRIP, annual income (after tax)
$115.48/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ACOPY beats the other by $114.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACOPY + ORCC for your $10,000?

ACOPY: 50%ORCC: 50%
100% ORCC50/50100% ACOPY
Portfolio after 10yr
$21.4K
Annual income
$68.45/yr
Blended yield
0.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ACOPY
No analyst data
Altman Z
15.4
Piotroski
7/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACOPY buys
0
ORCC buys
0
No recent congressional trades found for ACOPY or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACOPYORCC
Forward yield1.25%9.79%
Annual dividend / share$0.08$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$21.5K$21.4K
Annual income after 10y$135.86$1.04
Total dividends collected$1.3K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ACOPY vs ORCC ($10,000, DRIP)

YearACOPY PortfolioACOPY Income/yrORCC PortfolioORCC Income/yrGap
1$10,825$125.26$11,190$489.61$365.00ORCC
2$11,710$126.73$12,229$256.01$519.00ORCC
3$12,658$128.12$13,216$130.74$558.00ORCC
4$13,673$129.43$14,207$66.02$534.00ORCC
5$14,761$130.66$15,234$33.17$473.00ORCC
6$15,926$131.83$16,317$16.62$391.00ORCC
7$17,174$132.93$17,468$8.32$294.00ORCC
8$18,510$133.97$18,695$4.16$185.00ORCC
9$19,940$134.94$20,006$2.08$66.00ORCC
10← crossover$21,472$135.86$21,407$1.04+$65.00ACOPY

ACOPY vs ORCC: Complete Analysis 2026

ACOPYStock

The a2 Milk Company Limited, together with its subsidiaries, sells A2 protein type branded milk and related products in Australia, New Zealand, China, other Asian countries, and the United States. The company offers fresh milk under the a2 Milk brand; and infant formula under the a2 Platinum brand. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Company Limited in April 2014. The a2 Milk Company Limited was incorporated in 2000 and is based in Auckland, New Zealand.

Full ACOPY Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this ACOPY vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACOPY vs SCHDACOPY vs JEPIACOPY vs OACOPY vs KOACOPY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.